Bristol Myers Squibb (BMY) Q3 2022 Earnings Call Transcript

BMY earnings call for the period ending September 30, 2022.

Related Keywords

Japan , Germany , Netherlands , France , Japanese , Andrew Baum , Chris Boerner , Chris Shibutani , Terence Flynn Morgan Stanley , Terence Flynn , Giovanni Caforio , Andrew Baum Citi , Carter Gould Barclays , Steve Scala Cowen , Seamus Fernandez Guggenheim , David Elkins , Dane Leone , Mohit Bansal , William Blair , Luisa Hector , Robyn Karnauskas , Tim Anderson , Evan Seigerman , Luisa Hector Berenberg , Carter Gould , Bristol Myers Squibb , Matt Phipps William Blair , Samit Hirawat , Chris Schott Jpmorgan , Seamus Fernandez , Robyn Karnauskas Truist , Steven Scala , Chris Shibutani Goldman Sachs , Dane Leone Raymond James , Chris Schott , Matthew Phipps , Colin Bristow , Morgan Stanley , Tim Anderson Wolfe Research Analyst , Head Of Global Drug Development , Goldman Sachs , Wolfe Research , Company Analyst , Barclays , Wells Fargo , Stim Power , Chief Executive , Turning Point , Bristol Myers , Turning Point Therapeutics , Medical Officer , Global Drug , Maybei Ll , Capital Markets , Fargo Securities , Chief Commercialization , Chief Medical Officer , Berenberg Capital Markets ,